Nosopharm is formerly owned by UI Investissement, through Pertinence Invest 3 (PI3), since 2019.

When did UI Investissement acquire Nosopharm?

UI Investissement acquired Nosopharm in 2019 and exited after 4 years.

Has Nosopharm been sold?

Yes. Nosopharm was exited in 2023.

Healthcare·

France·Exited 2023·Held 4yr

Nosopharm is a healthcare company, headquartered in France.

Entry

2019

Hold

4yr

Exit

2023

Est. EV

–

Investor

HQFrance

SectorHealthcare

Discovers new antibiotics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Pertinence Invest 3 (PI3)

6 comparable healthcare deals from other GPs

Exit details: type, year, MOIC (buyer on Pro)

Already a member? Sign in

Data refreshed weekly · Sourced from public filings